Everolimus

Impact of p-mTOR expression on molecular-guided therapy in PDAC

Hossein Taghizadeh

CDK4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer

Q-TWiST of lenvatinib + everolimus in advanced RCC

Real-world: efficacy of everolimus + exemestane HR+, HER2- BC

Analysis of OS based on early tumor shrinkage in the phase III METEOR study

Achieving better response rates in metastatic RCC

Bradley McGregor

The agents at the forefront of kidney cancer treatment

Changing the standard of care in previously treated metastatic renal cell carcinoma

Laurence Albiges

CheckMate 025: Phase 3 trial of nivolumab for advanced kidney cancer

Padmanee Sharma

AZD2014 for treating ER+ metastatic breast cancer – mode of action and trial results

Cabozantinib for advanced renal cell carcinoma: the METEOR and CABOSUN trials

Phase III METEOR trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma

CABOSUN trial of cabozantinib – could it change how we treat frontline RCC?

Results of trial of ribociclib with everolimus and exemestane in breast cancer

Mafalda Olivera

Current landscape and future direction in systemic therapy for renal cell carcinoma (RCC)